Safety Review Committees (SRCs) and Data Monitoring Committees (DMCs) make critical decisions based on increasingly complex clinical trial data. Yet many review processes still depend on static reports that make it difficult to investigate emerging safety signals, answer questions during meetings, and understand the clinical context behind a finding. 

In this webinar, experts from MMS will explore how interactive safety visualizations can help SRCs and DMCs move beyond traditional review workflows. The session will show how reviewers can move directly from a potential signal to the underlying participant-level data, investigate questions during live discussions, and gain a clearer view of emerging safety trends. 

The speakers will demonstrate how Datacise®, MMS’s interactive clinical data review platform, can bring laboratory findings, adverse events, dosing information, concomitant medications, and participant-level trends together in one environment. They will also discuss how interactive review can reduce follow-up requests, improve traceability, support reviewer independence, and enable more timely safety decisions.

Led by:
Chris Schoonmaker, Chief Operating Officer, MMS
Andrew Mills, Strategic Principal Statistician, MMS
Kris Wenzel, Director, Data Science, MMS